Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131
Karen L. Smith, Fengmin Zhao, Ingrid A. Mayer, Amye J. Tevaarwerk*, Sofia F. Garcia, Carlos L. Arteaga, William F. Symmans, Ben H. Park, Brian L. Burnette, Della F. Makower, Margaret Block, Kimberly A. Morley, Chirag R. Jani, Craig Mescher, Shabana J. Dewani, Ursa Brown-Glaberman, Lisa E. Flaum, Erica L. Mayer, William M. Sikov, Eve T. RodlerAngela M. DeMichele, Joseph A. Sparano, Antonio C. Wolff, Kathy D. Miller, Lynne I. Wagner
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131'. Together they form a unique fingerprint.